PURPOSE: To retrospectively report the outcome of head and neck cancer patients following re-irradiation. PATIENTS AND METHODS: A total of 51 patients with recurrent or second primary head and neck cancer received re-irradiation at Leuven University Hospital. Survival and locoregional control were calculated. Doses to organs at risk were retrieved from dose-volume histograms. Radiation-related toxicities were reported. RESULTS: The 2-year actuarial overall survival rate was 30%. On univariate analysis, surgery before re-irradiation and high radiation dose were associated with superior survival. Grade 3 acute and grade 3 or more late toxicity occurred in respectively 29.4% and 35.3% of the patients. CONCLUSION: Re-irradiation in head and neck cancer patients is feasible with acceptable late toxicity, although the survival remains poor.
PURPOSE: To retrospectively report the outcome of head and neck cancerpatients following re-irradiation. PATIENTS AND METHODS: A total of 51 patients with recurrent or second primary head and neck cancer received re-irradiation at Leuven University Hospital. Survival and locoregional control were calculated. Doses to organs at risk were retrieved from dose-volume histograms. Radiation-related toxicities were reported. RESULTS: The 2-year actuarial overall survival rate was 30%. On univariate analysis, surgery before re-irradiation and high radiation dose were associated with superior survival. Grade 3 acute and grade 3 or more late toxicity occurred in respectively 29.4% and 35.3% of the patients. CONCLUSION: Re-irradiation in head and neck cancerpatients is feasible with acceptable late toxicity, although the survival remains poor.
Authors: A W Lee; W Foo; S C Law; Y F Poon; W M Sze; S K O; S Y Tung; W H Lau Journal: Int J Radiat Oncol Biol Phys Date: 1997-04-01 Impact factor: 7.038
Authors: A A Forastiere; B Metch; D E Schuller; J F Ensley; L F Hutchins; P Triozzi; J A Kish; S McClure; E VonFeldt; S K Williamson Journal: J Clin Oncol Date: 1992-08 Impact factor: 44.544
Authors: Sandra Nuyts; Piet Dirix; Paul M J Clement; Vincent Vander Poorten; Pierre Delaere; Joseph Schoenaers; Robert Hermans; Walter Van den Bogaert Journal: Int J Radiat Oncol Biol Phys Date: 2008-08-15 Impact factor: 7.038
Authors: R De Crevoisier; J Bourhis; C Domenge; P Wibault; S Koscielny; A Lusinchi; G Mamelle; F Janot; M Julieron; A M Leridant; P Marandas; J P Armand; G Schwaab; B Luboinski; F Eschwege Journal: J Clin Oncol Date: 1998-11 Impact factor: 44.544
Authors: Margaret Patterson; Rowena Brain; Ronald Chin; David Veivers; Michael Back; Andrew Wignall; Thomas Eade Journal: Dysphagia Date: 2014-08-13 Impact factor: 3.438
Authors: Luca Tagliaferri; György Kovács; Rosa Autorino; Ashwini Budrukkar; Jose Luis Guinot; Guido Hildebrand; Bengt Johansson; Rafael Martìnez Monge; Jens E Meyer; Peter Niehoff; Angeles Rovirosa; Zoltàn Takàcsi-Nagy; Nicola Dinapoli; Vito Lanzotti; Andrea Damiani; Tamer Soror; Vincenzo Valentini Journal: J Contemp Brachytherapy Date: 2016-08-26
Authors: Kelly K Curtis; Helen J Ross; Ashley L Garrett; Theresa A Jizba; Ajay B Patel; Samir H Patel; William W Wong; Michele Y Halyard; Stephen J Ko; Heidi E Kosiorek; Robert L Foote Journal: Radiat Oncol Date: 2016-04-09 Impact factor: 3.481